Recurrence of membranous nephropathy three weeks' postrenal transplant: A surprise in store

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Membranous nephropathy (MN) may occur in the transplanted kidney, either as recurrent disease in patients who had MN as the cause of end-stage renal disease (ESRD) in the native kidney or de novo, in patients who had another cause of ESRD initially. The reported incidence of recurrent MN ranges between 10% and 45%. Clinical manifestations of recurrent MN are typically observed 13-15 months after transplantation, although they may be observed much earlier (within weeks). Our patient had a recurrence in three weeks. Recurrent disease can lead to loss of the allograft.

Cite

CITATION STYLE

APA

Kumar, A. N., Murlidharan, P., Patil, S., Balan, S., & Ramdas, P. (2018). Recurrence of membranous nephropathy three weeks’ postrenal transplant: A surprise in store. Saudi Journal of Kidney Diseases and Transplantation : An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 29(3), 705–708. https://doi.org/10.4103/1319-2442.235186

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free